Search Results for "Breast Pap Test Trial"

21:41 EST 9th February 2016 | BioPortfolio

Matching Channels

Sniff test

Schilling test

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Breast Lumps


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Matching News

Oncotype DX Trial: Some Breast Cancers Don't Need Chemo

The first prospective data from the Oncotype DX breast cancer recurrence risk test are welcome, but there is a snag: the cut-off was changed for the trial. Medscape Medical News

Breast Cancer Tumor Test to Tailor Treatments

Breast Cancer Tumor Test to Tailor TreatmentsA diagnostic test helped guide treatment choices by successfully identifying women with a certain breast cancer type who didn’t need to undergo chemothe...

Blood test detects when hormone treatment for breast cancer stops working

Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treat...

DNA methylation test might predict breast cancer relapse

Every woman successfully treated for breast cancer lives with the knowledge that it could come back. New research published today in the journal Clinical Epigenetics may lead to a simple blood test to...

What to know before getting the genetic test for breast cancer

A genetic test to find out if people are more susceptible to breast cancer is available, but how do you decide whether to get it? With a lot of thought, cautioned Dr. Nora Hansen, director of the Lynn...

'Mutation-Tracking' Blood Test Could Predict Breast Cancer Relapse

Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumors are visible on hospital scans. The test can uncove... launches Metastatic Trial Search

(King + Company) has teamed up with five breast cancer advocacy organizations to make finding out about clinical trial options for metastatic breast cancer easier, faster, and m...

Test could predict whether breast cancer will spread to the brain

Women with particularly aggressive forms of breast cancer could be identified by a test that predicts whether the disease is likely to spread to the brain. An analysis of almost 4,000 patients with b...

Matching PubMed Articles

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.

In a phase 3, randomised, non-inferiority trial, accelerated partial breast irradiation (APBI) for patients with stage 0, I, and IIA breast cancer who underwent breast-conserving treatment was compare...

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

IMPORT HIGH is a multi-centre randomised UK trial testing dose escalated intensity modulated radiotherapy after tumour excision in women with early breast cancer and higher than average local recurren...

Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)?

Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01).

Serum levels of 25-OH vitamin D3 (vitamin D) have been shown to be prognostic for disease-free survival in patients with breast cancer. We investigated the predictive value of these levels for patholo...

Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.

Results of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial indicated that complete axillary node dissection (ALND) may not be warranted in some breast cancer patients with low tum...

Search Whole site using Google

Quick Search
Advertisement Advertisement